FDA Approvals - NCCN Updates Kidney Cancer Guidelines To Incorporate FDA Approval Of
NCCN Updates Kidney Cancer Guidelines To Incorporate FDA Approval Of Everolimus (Medical News Today)
The National Comprehensive Cancer Network (NCCN) has updated the NCCN Clinical Practice Guidelines in Oncology(TM) for Kidney Cancer to reflect the recent FDA approval of everolimus (Afinitor(R), Novartis) for advanced renal cell carcinoma in patients whose disease has progressed after treatment with kinase inhibitors such as sunitinib (Sutent(R), Pfizer Inc.
PowerRatings Weekly Outlook: PSSI, ABT, AEP, AMGN, CAG, BP (TradingMarkets.com via Yahoo! Finance)
The week itself was quite chaotic, starting out with surging volatility and steeply falling stock prices, but it looks like the week will end on a positive note. Here's a look at several of our PowerRated stocks featured this week.